Standalone Financial Result For The Period Ended On 30 September 2025
Filed with BSE · · 5 pages · English
1) The Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2025. 2) Limited Review Report by Statutory Auditors of the Company on Standalone Un-Audited Financial Results for the Quarter and Half year ended on 30th September, 2025. The meeting of the Board of Directors commenced at 03:30 P.M. and concluded at 04:25 P.M. MUKES MUKESH SHAH Amit Mukesh Shah M
Rekvina Laboratories Ltd. on 6ix
Earlier from Rekvina Laboratories
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November, 2025
- Rekvina Laboratories Ltd. Press Release Nov 05 2025
- Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th November, 2025.
- Rekvina Laboratories Ltd. Press Release Oct 13 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Rekvina Laboratories
- Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) (Amendment) Regulations, 2018, For The Half Year Ended On 30.09.2025.
- Rekvina Laboratories Ltd. Press Release Nov 14 2025
- Closure of Trading Window
- Rekvina Laboratories Ltd. Press Release Dec 26 2025
- Announcement under Regulation 30 (LODR)-Change in Directorate
Follow Rekvina Laboratories into a list and get an email when it puts out news.
Follow Rekvina Laboratories